Loading…
Evolved Ayurvedic Discoveries, Inc./BioCBDPlus was cited for marketing unapproved CBD drug products ("BioCBD+ Total Body Care," "BioCBD+ Topical Oil Muscle & Joint Support," and "BioCBD+ Peace Vape") in violation of sections 505(a) and 301(d) of the FD&C Act, as well as misbranding violations under section 502(f)(1). The company made disease claims on its website and social media platforms, including claims that the products could mitigate, prevent, treat, diagnose, or cure COVID-19, establishing them as unapproved new drugs. The inhalation product "BioCBD+ Peace Vape" was flagged as particularly concerning due to potential safety risks from ingredients and impurities that could trigger airway complications.